Fig 1: Comparison of results of expression levels of serum Hsp70 and ANXA1 in the groups of survival and death. (A) Comparison of results of expression levels of serum Hsp70 in the survival and death group. (B) Comparison of results of expression levels of serum ANXA1 in the survival and death group.*P<0.05, compared with death group. Hsp70, heat shock protein 70; ANXA1, Annexin A1.
Fig 2: ROC curves of expression levels of serum Hsp70 and ANXA1 in the diagnosis of death in patients with acutely severe traumatic brain injury. Hsp70, heat shock protein; ANXA1, Annexin A1.
Fig 3: Comparison of expression levels of serum Hsp70 and ANXA1 in the experimental group at different time points of admission and in the control group. (A) The results of expression of serum ANXA1 in the experimental group at different time points of admission and in the control group were compared. (B) The results of expression of serum Hsp70 in the experimental group at different time points of admission and in the control group were compared. *P<0.05, compared with the control group; #P<0.05, compared with one day after admission; &P<0.05, compared with two days after admission; %P<0.05, compared with three days after admission. Hsp70, heat shock protein 70; ANXA1, Annexin A1.
Supplier Page from Biorbyt for Human ANXA1 ELISA Kit
Application Notes: serum, plasma, tissue homogenates and other biological fluids.